{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:19:40Z","timestamp":1787008780302,"version":"build-2736575974"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:00:00Z","timestamp":1684454400000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Haematopoietic stem cell transplantation (HSCT) is a potentially curative therapy for several malignant and non-malignant haematologic conditions. Patients undergoing HSCT are at an increased risk of developing atrial fibrillation (AF). We hypothesized that a diagnosis of AF would be associated with poor outcomes in patients undergoing HSCT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>The National Inpatient Sample (2016\u201319) was queried with ICD-10 codes to identify patients aged &amp;gt;50 years undergoing HSCT. Clinical outcomes were compared between patients with and without AF. A multivariable regression model adjusting for demographics and comorbidities was used to calculate the adjusted odds ratio (aOR) and regression coefficients with corresponding 95% confidence intervals and P-values. A total of 50 570 weighted hospitalizations for HSCT were identified, out of which 5820 (11.5%) had AF. Atrial fibrillation was found to be independently associated with higher inpatient mortality (aOR 2.75; 1.9\u20133.98; P &amp;lt; 0.001), cardiac arrest (aOR 2.86; 1.55\u20135.26; P = 0.001), acute kidney injury (aOR 1.89; 1.6\u20132.23; P &amp;lt; 0.001), acute heart failure exacerbation (aOR 5.01; 3.54\u20137.1; P &amp;lt; 0.001), cardiogenic shock (aOR 7.73; 3.17\u201318.8; P &amp;lt; 0.001), and acute respiratory failure (aOR 3.24; 2.56\u20134.1; P &amp;lt; 0.001) as well as higher mean length of stay (LOS) (+2.67; 1.79\u20133.55; P &amp;lt; 0.001) and cost of care (+67 529; 36 630\u201398 427; P &amp;lt; 0.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Among patients undergoing HSCT, AF was independently associated with poor in-hospital outcomes, higher LOS, and cost of care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/europace\/euad129","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T21:37:24Z","timestamp":1684532244000},"source":"Crossref","is-referenced-by-count":8,"title":["Association of atrial fibrillation and outcomes in patients undergoing bone marrow transplantation"],"prefix":"10.1093","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6067-0506","authenticated-orcid":false,"given":"Satyam","family":"Krishan","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Oklahoma Health Sciences Center , 800 Stanton L. Young Blvd, AAT 5400, Oklahoma City, OK, 73104 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9804-898X","authenticated-orcid":false,"given":"Muhammad Bilal","family":"Munir","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Electrophysiology Section, University of California Davis , Davis, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8473-8069","authenticated-orcid":false,"given":"Muhammad Zia","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Medicine, West Virginia University , Morgantown, WV , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taha","family":"Al-Juhaishi","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Oklahoma Health Sciences Center , 800 Stanton L. Young Blvd, AAT 5400, Oklahoma City, OK, 73104 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4577-3248","authenticated-orcid":false,"given":"Ryan","family":"Nipp","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Oklahoma Health Sciences Center , 800 Stanton L. Young Blvd, AAT 5400, Oklahoma City, OK, 73104 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher V","family":"DeSimone","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic , Rochester, MN , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9560-1102","authenticated-orcid":false,"given":"Abhishek","family":"Deshmukh","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic , Rochester, MN , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4370-8135","authenticated-orcid":false,"given":"Stavros","family":"Stavrakis","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Oklahoma Health Sciences Center , 800 Stanton L. Young Blvd, AAT 5400, Oklahoma City, OK, 73104 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9935-8904","authenticated-orcid":false,"given":"Ana","family":"Barac","sequence":"additional","affiliation":[{"name":"Cardio Oncology Program, MedStar Heart and Vascular Institute, Georgetown University , Washington, DC , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3110-7049","authenticated-orcid":false,"given":"Zain Ul Abideen","family":"Asad","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Oklahoma Health Sciences Center , 800 Stanton L. Young Blvd, AAT 5400, Oklahoma City, OK, 73104 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,5,19]]},"reference":[{"key":"2023052001370857600_euad129-B1","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic stem-cell transplantation","volume":"354","author":"Copelan","year":"2006","journal-title":"N Engl J Med"},{"key":"2023052001370857600_euad129-B2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11912-019-0774-6","article-title":"Cardiac complications in the adult bone marrow transplant patient","volume":"21","author":"Tuzovic","year":"2019","journal-title":"Curr Oncol Rep"},{"key":"2023052001370857600_euad129-B3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/sj.bmt.1702783","article-title":"Severe cardiac toxicity in hematological stem cell transplantation: predictive value of reduced left ventricular ejection fraction","volume":"27","author":"Fujimaki","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"2023052001370857600_euad129-B4","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/ejh.13322","article-title":"Arrhythmias in hematopoietic stem cell transplantation: a systematic review and meta-analysis","volume":"103","author":"Chiengthong","year":"2019","journal-title":"Eur J Haematol"},{"key":"2023052001370857600_euad129-B5","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/sj.bmt.1704623","article-title":"Supraventricular tachyarrhythmias after hematopoietic stem cell transplantation: incidence, risk factors and outcomes","volume":"34","author":"Hidalgo","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"2023052001370857600_euad129-B6","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/bmt.2015.127","article-title":"Arrhythmias in the setting of hematopoietic cell transplants","volume":"50","author":"Tonorezos","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"2023052001370857600_euad129-B7","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/sj.bmt.1701217","article-title":"Paroxysmal atrial fibrillation after high-dose melphalan in five patients autotransplanted with blood progenitor cells","volume":"21","author":"Olivieri","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"2023052001370857600_euad129-B8","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1200\/JCO.20.02401","article-title":"Atrial fibrillation in patients undergoing allogeneic hematopoietic cell transplantation","volume":"39","author":"Chang","year":"2021","journal-title":"J Clin Oncol"},{"key":"2023052001370857600_euad129-B9","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/archinte.158.3.229","article-title":"Impact of atrial fibrillation on mortality, stroke, and medical costs","volume":"158","author":"Wolf","year":"1998","journal-title":"Arch Intern Med"},{"key":"2023052001370857600_euad129-B10","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/sj.neo.7900263","article-title":"The hypercoagulable state of malignancy: pathogenesis and current debate","volume":"4","author":"Caine","year":"2002","journal-title":"Neoplasia"},{"key":"2023052001370857600_euad129-B11","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.rec.2019.03.019","article-title":"Atrial fibrillation in active cancer patients: expert position paper and recommendations","volume":"72","author":"L\u00f3pez-Fern\u00e1ndez","year":"2019","journal-title":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"},{"key":"2023052001370857600_euad129-B12"},{"key":"2023052001370857600_euad129-B13","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1182\/blood-2014-02-514778","article-title":"Conditioning regimens for hematopoietic cell transplantation: one size does not fit all","volume":"124","author":"Gyurkocza","year":"2014","journal-title":"Blood"},{"key":"2023052001370857600_euad129-B14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.5152\/TJAR.2019.44789","article-title":"Atrial fibrillation in patients with septic shock: a one-year observational pilot study","volume":"47","author":"Steinberg","year":"2019","journal-title":"Turk J Anaesthesiol Reanim"},{"key":"2023052001370857600_euad129-B15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejim.2021.10.022","article-title":"Sepsis-driven atrial fibrillation and ischaemic stroke. Is there enough evidence to recommend anticoagulation?","volume":"98","author":"Induruwa","year":"2022","journal-title":"Eur J Intern Med"},{"key":"2023052001370857600_euad129-B16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.5455\/msm.2017.29.231-236","article-title":"The impact of risk factors and comorbidities on the incidence of atrial fibrillation","volume":"29","author":"Naser","year":"2017","journal-title":"Mater Sociomed"},{"key":"2023052001370857600_euad129-B17","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.atherosclerosis.2013.11.082","article-title":"Atherosclerosis and atrial fibrillation\u2014two closely intertwined diseases","volume":"233","author":"Willeit","year":"2014","journal-title":"Atherosclerosis"},{"key":"2023052001370857600_euad129-B18","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/jce.13458","article-title":"Obesity is associated with incident atrial fibrillation independent of gender: a meta-analysis","volume":"29","author":"Asad","year":"2018","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2023052001370857600_euad129-B19","doi-asserted-by":"crossref","first-page":"e750","DOI":"10.1097\/HS9.0000000000000750","article-title":"EHA guidelines on management of antithrombotic treatments in thrombocytopenic patients with cancer","volume":"6","author":"Falanga","year":"2022","journal-title":"Hemasphere"},{"key":"2023052001370857600_euad129-B20","doi-asserted-by":"crossref","first-page":"E112","DOI":"10.1002\/ajh.25045","article-title":"Safety of anticoagulation in patients with atrial fibrillation and MDS\/AML complicated by thrombocytopenia: an unresolved challenge: can they be managed? A report of three cases and literature review","volume":"93","author":"Caro","year":"2018","journal-title":"Am J Hematol"},{"key":"2023052001370857600_euad129-B21","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0735-1097(22)01147-0","article-title":"Atrial fibrillation predicts poor outcomes and higher cost of care in patients admitted for inpatient chemotherapy-insight from the National Inpatient Sample","volume":"79","author":"Krishan","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2023052001370857600_euad129-B22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejca.2022.07.019","article-title":"The association of cardiac arrhythmias with chimeric antigen receptor T cell therapy in hospitalised patients: insights from National Inpatient Sample","volume":"174","author":"Thotamgari","year":"2022","journal-title":"Eur J Cancer"},{"key":"2023052001370857600_euad129-B23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/6653971","article-title":"ECG markers of cardiovascular toxicity in adult and pediatric cancer treatment","volume":"2021","author":"Sp\u00eenu","year":"2021","journal-title":"Dis Markers"},{"key":"2023052001370857600_euad129-B24"},{"key":"2023052001370857600_euad129-B25","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/01.smj.0000257382.89910.fe","article-title":"Early and late arrhythmogenic effects of doxorubicin","volume":"100","author":"Kilickap","year":"2007","journal-title":"South Med J"},{"key":"2023052001370857600_euad129-B26","doi-asserted-by":"crossref","first-page":"e12534","DOI":"10.1111\/anec.12534","article-title":"The analysis of the parameters of 24-hr ECG Holter monitoring in patients with blood neoplasms undergoing high-dose chemotherapy and stem cell transplantation","volume":"23","author":"Por\u0119ba","year":"2018","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"2023052001370857600_euad129-B27","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.bbmt.2009.05.010","article-title":"Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation","volume":"15","author":"Majhail","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"2023052001370857600_euad129-B28","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1182\/blood-2012-06-437178","article-title":"Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease","volume":"120","author":"Armenian","year":"2012","journal-title":"Blood"},{"key":"2023052001370857600_euad129-B29","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejim.2022.08.004","article-title":"Adherence to the \u201cAtrial fibrillation Better Care\u201d (ABC) pathway in patients with atrial fibrillation and cancer: a report from the ESC-EHRA EURObservational Research Programme in atrial fibrillation (EORP-AF) General Long-Term Registry","volume":"105","author":"Vitolo","year":"2022","journal-title":"Eur J Intern Med"},{"key":"2023052001370857600_euad129-B30","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/europace\/euaa274","article-title":"Relation of outcomes to ABC (Atrial fibrillation Better Care) pathway adherent care in European patients with atrial fibrillation: an analysis from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry","volume":"23","author":"Proietti","year":"2021","journal-title":"Europace"},{"key":"2023052001370857600_euad129-B31","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur Heart J"},{"key":"2023052001370857600_euad129-B32","first-page":"690","article-title":"Pretransplant cardiac evaluation using novel technology","volume":"8","author":"Hemu","year":"2019","journal-title":"J Clin Med Res"},{"key":"2023052001370857600_euad129-B33","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/eurjpc\/zwaa054","article-title":"Anticoagulation in patients with atrial fibrillation and active cancer: an international survey on patient management","volume":"28","author":"Boriani","year":"2021","journal-title":"Eur J Prev Cardiol"}],"container-title":["Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/25\/5\/euad129\/50402362\/euad129.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/25\/5\/euad129\/50402362\/euad129.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T21:37:41Z","timestamp":1684532261000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/doi\/10.1093\/europace\/euad129\/7174152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5,19]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euad129","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,5]]},"published":{"date-parts":[[2023,5]]},"article-number":"euad129"}}